Search results
Results from the WOW.Com Content Network
The nine-item Patient Health Questionnaire (PHQ-9) is a depressive symptom scale and diagnostic tool introduced in 2001 to screen adult patients in primary care settings. . The instrument assesses for the presence and severity of depressive symptoms and a possible depressive disor
The Patient Health Questionnaire 2 item (PHQ-2) is an ultra-brief screening instrument containing the first two questions from the PHQ-9. [ 8 ] : 3 Two screening questions to assess the presence of a depressed mood and a loss of interest or pleasure in routine activities , and a positive response to either question indicates further testing is ...
The Patient Health Questionnaire-2 (PHQ-2) is a shorter version of the PHQ-9 with two screening questions to assess the presence of a depressed mood and a loss of interest or pleasure in routine activities; a positive response to either question indicates further testing is required. [10]
The SSD-12 can be used in combination with the Patient Health Questionnaire-15 (PHQ-15). [9] and the Somatic Symptom Scale-8 (SSS-8) [10] to identify persons at risk for SSD. [2] Optimal combined cutpoints were ⩾9 for the PHQ-15 or SSS-8, and ⩾23 for the SSD-12 (sensitivity and specificity = 69% and 70%) [8]
[23] [24] [25] and also in a research study regarding health-related quality of life measurement in children in Ibero-American countries. [26] The Quality of Life Index for Atopic Dermatitis (QoLIAD) measures the impact that atopic dermatitis has on a given patient's quality of life. [27] It is a 25 item questionnaire for patients over the age ...
The Montgomery–Åsberg Depression Rating Scale (MADRS) is a ten-item [1] diagnostic questionnaire which mental health professionals use to measure the severity of depressive episodes in patients with mood disorders.
The patient is rated by a clinician on 17 to 29 items (depending on version) scored either on a 3-point or 5-point Likert-type scale. For the 17-item version, a score of 0–7 is considered to be normal while a score of 20 or higher (indicating at least moderate severity) is usually required for entry into a clinical trial. [ 11 ]
A patient-reported outcome (PRO) is a health outcome directly reported by the patient who experienced it. It stands in contrast to an outcome reported by someone else, such as a physician -reported outcome, a nurse -reported outcome, and so on.